SOBRsafe Inc. Reports Significant Revenue Growth Driven by SOBRsure(TM) GEN 2 Sales

SOBRsafe Inc. (NASDAQ: SOBR), a pioneer in advanced alcohol monitoring and detection solutions, has reported a remarkable 92.3% year-over-year revenue growth in the second quarter of 2025, reaching $104,200. This surge is primarily fueled by the sales of SOBRsure(TM) GEN 2 hardware and software, which accounted for 76.5% of the total revenue. The company also saw a 380 basis points increase in gross margin to 57.5%, alongside a reduction in net loss to $2.0 million from $2.1 million in the same quarter the previous year.

The second quarter witnessed the shipment of 178 SOBRsure(TM) GEN 2 devices, a 35.9% increase from the first quarter, and a 109.6% year-over-year growth in annual recurring software subscription revenue, now making up 55.2% of the quarterly revenue. Operational achievements during this period included the independent third-party validation of SOBRsure(TM) GEN 2's performance, the launch of an enhanced B2B e-commerce platform, and the issuance of a European Patent for SOBRcheck(TM). Additionally, SOBRsafe expanded its sales team and entered the Family Law market, further diversifying its application areas.

As of June 30, 2025, SOBRsafe's cash and equivalents stood at $8.5 million, underscoring the company's solid financial position. For more detailed information, the full press release can be accessed here.

SOBRsafe's innovative approach to alcohol detection, utilizing next-generation transdermal technology, offers a passive and dignified method for screening and monitoring, eliminating the need for breath, blood, or urine samples. This technology is increasingly relevant across various sectors, including behavioral health, family law, and consumer markets, highlighting the company's potential for further growth and impact in the industry.